Info_Otros-Programas-Internacionales

Beste hainbat programa

**NARSAD - Brain and Behavior Research Foundation**
Laburpena	The Brain & Behavior Research Foundation is committed to alleviating the suffering caused by mental illness by awarding grants that will lead to advances and breakthroughs in scientific research.
Helburua	The focus of this foundation is to understand, prevent, and treat brain and behavioral disorders including autism, anxiety, depression, and others.
Modalitatea	There are three funding types as follows: Young Investigator Grants • For investigators at the post-doctoral or assistant professor level. • Two-year awards of US$35.000/year for pilot projects. • Annual call for applications in January-February Independent Investigator Grants • For independent researchers at the associate professor level. • Two-year awards of US$50.000/year. • Annual call for applications in November-December Distinguished Investigator Grants • For the full professor level. • One-year awards of US$100.000 • Annual call for applications in June-July
Esteka	https://bbrfoundation.org/grants

**European Molecular Biology Organisation (EMBO)**
Laburpena	EMBO is an organization that promotes excellence in life science careers, with an emphasis on molecular biology.
Helburua	EMBO helps young scientists to advance their research, promote their international reputations and ensure their mobility. Courses, workshops, conferences and EMBO Press publications disseminate the latest research and offer training in techniques to maintain high standards of excellence in research practice. EMBO helps to shape science policy by seeking input and feedback from our community and by following closely the trends in science in Europe.
Modalitatea	It provides support through the following mechanisms: Short-Term and Long-Term, and European Respiratory Society (ERS) Fellowships • Intended for postdoctoral-level researchers • Funding to return to a home lab (short-term), to work abroad (long-term), or to recruit more respiratory clinicians into research (ERS) • Application deadlines: Ongoing (short-term); annually, February 12 and August 12 (long-term); and annually, January, April, and October (ERS) Young Investigators: • For the assistant professor level • Funding of 15.000€ and an extensive network of opportunities for mentoring and professional development. • Annual application deadline, April 1 Travel and Lecture Grants • Funding to attend or organize EMBO events
Esteka	http://www.embo.org/funding-awards

**U.S. National Institutes of Health (NIH)**
Laburpena	The U.S. National Institutes of Health fund a wide variety of biomedical projects in fields such as cancer biology, vaccine development, mental health biology, drug and alcohol addiction treatments, bioinformatics, and many more, with new opportunities announced weekly.
Helburua	Non-U.S.-based research groups must either provide evidence that they can contribute a unique resource that is not available in the U.S. (e.g., a unique collection of samples) OR they may act as the sub-contractor of a U.S.-based collaborator.
Modalitatea	NIH offers funding for many types of grants, contracts, and programs.
Esteka	https://grants.nih.gov/grants/guide/index.html

**Worldwide Cancer Research**
Laburpena	Translational cancer research
Helburua	This foundation provides financing for projects that could reduce the incidence of cancer or improve cancer survival.
Modalitatea	Projects of 12-36 months will be funded for up to 250.000 £. Applications are due annually in April or October.
Esteka	http://www.worldwidecancerresearch.org/funding/make-an-application

Informazio gehiago: proyectoseuropeos@ehu.eus

Bizitzaren Zientzen Proiektuak

ONO-SM-362n 1-fosfato zeramikak eragindako fenomenoari buruzko azterketa

Programa espezifikoa: ONO Lankidetza Farmazeutikoko Proiektua
UPV/EHU: Bazkidea
UPV/EHU IP: Antonio Gómez Muñoz

Proiektuaren hasiera: 2014/10/07
Proiektuaren amaiera: 2016/11/30

Deskribapen laburra:
Proiektuak ONO-SM-362 konposatuak 1-fosfato (C1P) zeramikak pankreako minbizi-zelulen heriotzan eragindako zenbait efektutan dituen ondorioak aztertzen ditu, oso modu eraginkorrean. Ekintza horiek zelulen biziraupena eragiten dute, eta, azkenean, tumorogenesia. Gainera, C1Pak hanturazko erantzunak eragin ditzake, eta horietako batzuk tumoreak sustatzearekin lotuta egon daitezke. Proiektuak proposatzen du ONO-SM-362 konposatuak gutxienez C1Pak giza zelula pankreatikoetan dituen ondorio kaltegarrietako batzuk indargabetu ditzakeela, eta, era berean, hanturari eragin diezaiokeela makrofagoetan eragindako ekintzen bidez.